Literature DB >> 7964854

Indications for intravenous gammaglobulin therapy in inflammatory myopathies.

P Cherin1, S Herson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964854      PMCID: PMC1016726          DOI: 10.1136/jnnp.57.suppl.50

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  31 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

3.  Gamma-globulin therapy in 6 newly diagnosed diabetic children.

Authors:  E Heinze; A Thon; U Vetter; G Gaedicke; K Zuppinger
Journal:  Acta Paediatr Scand       Date:  1985-07

4.  [Physiopathogeny of dermatomyositis and polymyositis].

Authors:  P Chérin; S Herson; P Godeau
Journal:  Ann Med Interne (Paris)       Date:  1990

5.  Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopenia.

Authors:  D Engelhard; J L Waner; N Kapoor; R A Good
Journal:  J Pediatr       Date:  1986-01       Impact factor: 4.406

6.  Human placenta-eluted gammaglobulins in immunomodulating treatment of rheumatoid arthritis.

Authors:  B Combe; B Cosso; J Clot; M Bonneau; J Sany
Journal:  Am J Med       Date:  1985-06       Impact factor: 4.965

7.  High-dose intravenous gammaglobulin for myasthenia gravis.

Authors:  P Gajdos; H Outin; D Elkharrat; D Brunel; P de Rohan-Chabot; J C Raphael; M Goulon; C Goulon-Goeau; E Morel
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

8.  Treatment of dermatomyositis with intravenous gammaglobulin.

Authors:  B A Lang; R M Laxer; G Murphy; E D Silverman; C M Roifman
Journal:  Am J Med       Date:  1991-08       Impact factor: 4.965

Review 9.  Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders.

Authors:  P H Plotz; M Dalakas; R L Leff; L A Love; F W Miller; M E Cronin
Journal:  Ann Intern Med       Date:  1989-07-15       Impact factor: 25.391

10.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  3 in total

Review 1.  [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

Review 2.  Recognition and management of myositis.

Authors:  P Cherin
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

3.  Outcome of patients having dermatomyositis admitted to the intensive care unit.

Authors:  Yaniv Sherer; Daniel Shepshelovich; Tamara Shalev; Yael Haviv; Eran Segal; Michael Ehrenfeld; Yair Levy; Rachel Pauzner; Yehuda Shoenfeld; Pnina Langevitz
Journal:  Clin Rheumatol       Date:  2007-02-27       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.